Dr. Lisa Erlanger is joining us for part 2 of a virtual discussion exploring what weight inclusive providers need to know about GLP-1/semaglutide medications (e.g. Ozempic, Mounjaro, etc.) .

Approved for 1.5 CEU for RDNs.

Register here. FREE for WIND Members, $25-35 for non-members